XML 34 R26.htm IDEA: XBRL DOCUMENT v3.23.2
Sale of Freeline Therapeutics GmbH (Tables)
6 Months Ended
Jun. 30, 2023
Discontinued Operations and Disposal Groups [Abstract]  
Summary of Company's Book Value of Assets and Liabilities Sold he table below sets forth the book value of the Freeline Therapeutics GmbH assets and liabilities sold along with the calculation of the gain on sale based on the cash consideration received.

 

 

 

(in thousands)

 

Book value of assets sold

 

 

 

Cash and cash equivalents

 

$

1,015

 

Prepaid expenses and other current assets

 

 

414

 

Property and equipment, net

 

 

5,470

 

Operating lease right of use assets

 

 

8,455

 

Other non-current assets

 

 

3

 

Amounts attributable to assets sold

 

 

15,357

 

Book value of liabilities sold

 

 

 

Accounts payable

 

 

230

 

Accrued expenses and other current liabilities

 

 

1,430

 

Operating lease liabilities, current

 

 

869

 

Operating lease liabilities, non-current

 

 

8,044

 

Amounts attributable to liabilities sold

 

 

10,573

 

Total identifiable net assets sold

 

 

4,784

 

Less: accumulated other comprehensive loss

 

 

(155

)

Consideration, inclusive of cash transferred

 

 

25,218

 

Gain on sale of Freeline Therapeutics GmbH

 

$

20,279